Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
The Worldwide Aspiration & Biopsy Needles Industry is Expected to Reach $1.3 Billion by 2028 | ||
By: PR Newswire Association LLC. - 30 Jun 2022 | Back to overview list |
|
DUBLIN, June 30, 2022 /PRNewswire/ -- The 'Global Aspiration & Biopsy Needles Market Size, Share & Industry Trends Analysis Report By Product Type, By Procedure, By Image-guided Type, By End User, By Application, By Tumor/ Cancer Applications Type, By Regional Outlook and Forecast, 2022-2028' report has been added to ResearchAndMarkets.com's offering. The Global Aspiration & Biopsy Needles Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period. Advanced imaging technologies, such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, CT scan, and others, can be used in conjunction with traditional biopsy techniques to perform a biopsy with accuracy and least invasiveness. Biopsies of body organs such as the liver, lungs, and kidneys are performed using these integrated methods. Cancer screening, cancer management visits, and cancer biopsy procedures have all decreased significantly as a result of the COVID-19 outbreak. Cancer screening services were hampered to some extent as a result of the lockdowns, which reduced the demand for biopsy needles. In a study conducted in the United Kingdom and published in Lancet Oncology in March 2021, the consequences of delayed cancer detection due to COVID-19 were studied. Over 90,000 patients with breast, colorectal, esophageal, or lung cancer were included in the study. It was discovered that the COVID-19 pandemic will have a significant impact on 1- and 5-year cancer survival rates because of a decrease in diagnostic biopsies and a lack of screening services. Rising Incidences of Cancer There has been a spike in the number of people diagnosed with cancer around the world. This can be due to a variety of factors, including changes in lifestyle, bad diets, and increased cigarette use. According to the International Agency for Research on Cancer (IARC), 17.0 million new cancer cases and 9.5 million cancer deaths occurred globally in 2018. The global burden of cancer is anticipated to rise to 27.5 million new cases and 16.3 million deaths by 2040, owing to population expansion and aging. Disruptive business trends are expected as spanning from shifting supply chains to cost savings, automation, and a focus on customers. Companies that recognize and align their operations with industry trends will gain significant Market share. In the aspiration and biopsy needles Market, emerging Market s such as India, China, Brazil, and Mexico are expected to provide considerable growth potential for competitors. This can be ascribed to increased healthcare expenditures, improved living conditions, a broad target population base, improved and expanded healthcare infrastructure, and modernization of healthcare research and facilities in these countries. Reusing Aspiration and Biopsy Needles Poses Risk of Infection to Patients Radiologists and surgeons use biopsy needle procedures such as core-needle and fine-needle procedures to examine anomalies at a specific spot. Patients may, however, get infections as a result of the cuts and incisions used to remove tissue samples. Furthermore, aspiration and biopsy needles are frequently reused, raising the infection risk during these procedures. Despite the fact that the reuse of some needles is discouraged by healthcare authorities and product manufacturers, the practice persists, particularly in developing nations. Key Topics Covered: For more information about this report visit https://www.researchandmarkets.com/r/clbazw Media Contact: Research and Markets For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1907 View original content:https://www.prnewswire.com/news-releases/the-worldwide-aspiration--biopsy-needles-industry-is-expected-to-reach-1-3-billion-by-2028--301578779.html SOURCE Research and Markets |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |